Saturday - August 2, 2025
UM Miller School of Medicine: Clinical Study on Targeted Drug Expands Treatment Options for Myelodysplastic Syndrome
July 25, 2025
MIAMI, Florida, July 25 (TNSjou) -- The University of Miami Miller School of Medicine issued the following news:

* * *

Clinical Study on Targeted Drug Expands Treatment Options for Myelodysplastic Syndrome

Summary

* The drug olutasidenib targets a mutation linked to some cases of myelodysplastic syndrome (MDS), a potentially deadly condition that can progress to leukemia.

* Researchers at Sylvester Comprehensive Cancer Center led c . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products